# Access Vascular

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/access-vascular

- Industry: Medical Devices & Equipment
- Headquarters: Billerica, US
- Website: www.accessvascularinc.com
- Total disclosed funding: $20M
- Latest round: Series B (Mar 3, 2021)
- Investors on record: 1

## About

Based in Massachusetts, US, and founded in 2015, Access Vascular, Inc. is a company that focuses on the most prevalent and expensive venous access complications. James Biggins is the founder, President, and CEO of the company. In March 2021, the company raised USD 20 million in series B funding led by new investor TVM Capital Life Science, with participation from unspecified investors.

The company develops a line of venous access devices made from proprietary hydrophilic biomaterials that are highly biocompatible and provide long-term resistance to thrombus, prevent infections and phlebitis. The company’s product devices include HydroPICC (peripherally inserted central venous catheter) and HydroMID (midline catheter).

The company plans to expand its material platform to potentially provide long-term infection protection and minimize vessel trauma during catheter insertion.

## Funding rounds

- Series B, Mar 3, 2021, $20M — TVM Capital Life Science

## Investors

- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series B